Dec 15 (Reuters) - Dren Bio, a private biotech company, said on Monday it has entered into a strategic collaboration with Sanofi to develop therapies for autoimmune diseases in a deal worth up to $1.7 billion.
(Reporting by Sneha S K; Editing by Sahal Muhammed)